InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: mrmainstreet post# 26158

Thursday, 03/20/2014 10:51:31 AM

Thursday, March 20, 2014 10:51:31 AM

Post# of 425934
"market Vascepa for Mixed Dyslipidemia, with the tacit agreement to acknowledge, that there was no data as yet to prove that lowering Trgs improved Patient Outcomes"

For me it is not label compromise, it is exactly what they would like to get ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News